Neerav D. Padliya

  • Facebook
  • Twitter
  • Pinterest
  • Instagram

Neerav Dilip Padliya, PhD, PMP is vice president, research alliances at Qurr. His career success began in 2006 at Celgene Corporation, where he was the principal investigator behind a highly interdisciplinary program focused on mass spectrometry-based proteomic studies of placenta-derived populations of stem cells and natural killer cells. Dr. Padliya…

Neerav Dilip Padliya, PhD, PMP is vice president, research alliances at Qurr. His career success began in 2006 at Celgene Corporation, where he was the principal investigator behind a highly interdisciplinary program focused on mass spectrometry-based proteomic studies of placenta-derived populations of stem cells and natural killer cells.

Dr. Padliya spearheaded collaborations with Immunologists and cell biologists that led to the issue of two U.S. patents, one pending U.S. patent application, and the publication of one journal article as senior author. In 2011, Dr. Padliya joined AB SCIEX, (a wholly owned operating company of Danaher Corporation), a premier manufacturer of high-end mass spectrometry instrumentation used for applications in pharmaceuticals, clinical laboratories, environmental monitoring, and the food and beverage industry.

More About the Author Less About the Author

Neerav Dilip Padliya, PhD, PMP is vice president, research alliances at Qurr. His career success began in 2006 at Celgene Corporation, where he was the principal investigator behind a highly interdisciplinary program focused on mass spectrometry-based proteomic studies of placenta-derived populations of stem cells and natural killer cells. Dr. Padliya…

Neerav Dilip Padliya, PhD, PMP is vice president, research alliances at Qurr. His career success began in 2006 at Celgene Corporation, where he was the principal investigator behind a highly interdisciplinary program focused on mass spectrometry-based proteomic studies of placenta-derived populations of stem cells and natural killer cells.

Dr. Padliya spearheaded collaborations with Immunologists and cell biologists that led to the issue of two U.S. patents, one pending U.S. patent application, and the publication of one journal article as senior author. In 2011, Dr. Padliya joined AB SCIEX, (a wholly owned operating company of Danaher Corporation), a premier manufacturer of high-end mass spectrometry instrumentation used for applications in pharmaceuticals, clinical laboratories, environmental monitoring, and the food and beverage industry.

More About the Author Less About the Author

Latest by Neerav D. Padliya